Home › Funds › venBio Partners LLC › HRMY
venBio Partners LLC position in HRMY
HARMONY BIOSCIENCES HLDGS IN · Health Care
venBio Partners LLC reported holding 472,194 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q2 2026 13F filing — a position valued at US$17.2M, representing 3.31% of its reported portfolio and ranking #6 among its reported holdings. venBio Partners LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How venBio Partners LLC's HRMY position evolved
venBio Partners LLC first disclosed a stake in HRMY in Q3 2023 at 1,035,396 shares (US$33.9M). The position peaked in Q1 2024 at 1,035,396 shares, worth US$34.8M. Across 12 filings, venBio Partners LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 472,194 shares valued at US$17.2M — a reduction of -17,000 shares quarter over quarter.. Notable position changes include a 41% trim in Q3 2024 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.04M | $33.93M | New |
| Q4 2023 | 1.04M | $33.44M | Hold |
| Q1 2024 | 1.04M | $34.77M | Hold |
| Q2 2024 | 1.04M | $31.24M | Hold |
| Q3 2024 | 614.59K | $24.58M | Reduce |
| Q4 2024 | 539.19K | $18.55M | Reduce |
| Q1 2025 | 489.19K | $16.24M | Reduce |
| Q2 2025 | 489.19K | $15.46M | Hold |
| Q3 2025 | 489.19K | $13.48M | Hold |
| Q4 2025 | 489.19K | $18.31M | Hold |
| Q1 2026 | 489.19K | $13.70M | Hold |
| Q2 2026 | 472.19K | $17.19M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HRMY and 13F data
HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 36 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HRMY
- ARMISTICE CAPITAL, LLC 1.56M sh · $56.95M · Q2 2026
- Valor Management LLC 818.01K sh · $29.78M · Q2 2026
More on venBio Partners LLC
FAQ
How long has venBio Partners LLC held HRMY?
venBio Partners LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is venBio Partners LLC's current position in HRMY?
As of Q2 2026, venBio Partners LLC holds 472.19K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $17.19M, representing 3.31% of its reported portfolio and ranking #6.
Has venBio Partners LLC been buying or selling HRMY?
In the latest 13F filing (Q2 2026), venBio Partners LLC reduced its position in HRMY. The position peaked in Q1 2024 at 1.04M shares.
Which other funds hold HRMY?
Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.